News

Here are my 7 Investing Lessons From The Big Short...These lessons apply to all investing, not just cryptocurrency or shorting the U.S housing market.

Phase 2 trial for non-opioid chronic cough therapy initiated just 6 months after Series A funding (Image: Attenua)

This ETF’s label plays on the false “Retail Apocalypse” narrative and our holdings-based research shows that this ETF buys low-quality, overvalued stocks and shorts high-quality, undervalued stocks.

While there are many different businesses options that women can use to create income and find a significant sense of empowerment, real estate may be one of the best.

Will it be a good deal? No matter what's in the deal, the answer is likely "No."

Investing Strategies

Interesting Investments: Drugs

Interesting Investments: Drugs

It's once again time to go into a gray area of investing. Can drugs like marijuana be profitable? What about lesser-known drugs? Investing directly or in related industries, there's money…

Justice Deptartment, SEC Seek Information from Snap Over IPO Claims

Justice Deptartment, SEC Seek Information from Snap Over IPO Claims

The investigations are based on a class-action lawsuit filed last year.

Financial Impact of Midterm Elections: Do the Markets Really Care About the Results?

Financial Impact of Midterm Elections: Do the Markets Really Care About the Results?

What do the experts have to say about where we are headed next?

Private Markets Investing

​10 Signs You Are an Entrepreneur

​10 Signs You Are an Entrepreneur

Anyone can be an entrepreneur. Sometimes it’s born out of need, sometime it is opportunistic or maybe it’s the only option.

Liabilities That Can Destroy Even Very Promising Startups

Liabilities That Can Destroy Even Very Promising Startups

Liabilities can topple even the best startups through freezing cash flow.

3 Reliable Ways to Win the Heart of an Angel Investor

3 Reliable Ways to Win the Heart of an Angel Investor

Getting funding from angel investors isn't supposed to be rocket science. To get them, connect with their emotions and get your facts and numbers straight and show them an exit…

Stocks

Justice Deptartment, SEC Seek Information from Snap Over IPO Claims

Justice Deptartment, SEC Seek Information from Snap Over IPO Claims

The investigations are based on a class-action lawsuit filed last year.

Why Cryptocurrency Banking Could be Less Taxing in Singapore

Why Cryptocurrency Banking Could be Less Taxing in Singapore

Singapore is lauded as one of the most crypto-friendly countries. Here's why.

Will a Robot Take Your Job?

Will a Robot Take Your Job?

Is your job going the way of the robots? The Future of Jobs Report estimates the changes robotics will bring to the workplace over the next few years.

Economy/Politics

How the Real Estate Industry Can Empower Women

How the Real Estate Industry Can Empower Women

While there are many different businesses options that women can use to create income and find a significant sense of empowerment, real estate may be one of the best.

Brexit Compromise? Not So Fast! Collapse of UK Governments Just as Likely

Brexit Compromise? Not So Fast! Collapse of UK Governments Just as Likely

Will it be a good deal? No matter what's in the deal, the answer is likely "No."

​Democrats and Republicans Are Their Own Worst Enemies

​Democrats and Republicans Are Their Own Worst Enemies

The stock markets, of course, go gangbusters in a stimulus driven bubble… and this one is the one to end all bubbles.

White House Says It Has 'Broad Discretion' on Press Access

White House Says It Has 'Broad Discretion' on Press Access

The Trump administration responds to the legal challenge from CNN and other outlets over the revocation of journalist Jim Acosta's "hard pass."

Markets

Why Holdings-Based Research Matters: Avoid This Micro-Bubble ETF

Why Holdings-Based Research Matters: Avoid This Micro-Bubble ETF

This ETF’s label plays on the false “Retail Apocalypse” narrative and our holdings-based research shows that this ETF buys low-quality, overvalued stocks and shorts high-quality, undervalued stocks.

Special Sections

Attenua Treats First Patient in Phase 2 Study for Chronic Cough

Attenua Treats First Patient in Phase 2 Study for Chronic Cough

Phase 2 trial for non-opioid chronic cough therapy initiated just 6 months after Series A funding (Image: Attenua)

Gene-Edited Food Is Coming, but Will Shoppers Buy?

Gene-Edited Food Is Coming, but Will Shoppers Buy?

A new generation of biotech foods is getting close to the grocery aisles.

Genentech Gets FDA Priority Review Designation for Combination Treatment of Triple-Negative Breast Cancer

Genentech Gets FDA Priority Review Designation for Combination Treatment of Triple-Negative Breast Cancer

Tecentriq-Abraxane combination would be the first cancer immunotherapy for PD-L1-positive, metastatic triple-negative breast cancer (Image: Mayo Clinic)

5 Things to Know About Moderna's Proposed $500 Million IPO

5 Things to Know About Moderna's Proposed $500 Million IPO

The proposed deal for this biotechnology unicorn would be the largest US IPO in the industry (Image: Moderna)